Home › Ovarian Cancer › Indiana › Gary
Ovarian Cancer clinical trials in Gary, IN
4 studies for Ovarian Cancer are looking for participants at sites in and around Gary (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
- Woodland Cancer Care Center, Michigan City · 25 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Northwest Cancer Center - Hobart, Hobart · 6 mi away
- Saint Mary Medical Center, Hobart · 6 mi away
- Northwest Cancer Center - Crown Point, Crown Point · 12 mi away
- and 2 more
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- UChicago Medicine - Northwest Indiana, Crown Point · 12 mi away
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX90 studies
- New York City, NY75 studies
- Boston, MA62 studies
- Los Angeles, CA53 studies
- Nashville, TN50 studies
- Arlington, VA47 studies
- Philadelphia, PA47 studies
- Columbus, OH39 studies
- St. Louis, MO37 studies
- Chicago, IL36 studies
- San Antonio, TX33 studies
- Pittsburgh, PA32 studies
Other studies in Gary
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Acute Myeloid Leukemia5 studies
- Heart Failure5 studies
- Breast Cancer4 studies
- Atrial Fibrillation4 studies
- COPD3 studies
- Blood Clots3 studies
- Esophageal Adenocarcinoma3 studies
- Endometrial Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.